Balsalazide The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Balsalazide. Bemiparin The risk or severity of bleeding can be increased when Bismuth subsalicylate is
A medication used to treat a certain type of leukemia, a blood and bone marrow cancer, after other treatments have been used. DrugBank ID DB12688 Type Biotech US Approved YES Other Approved YES Patents 0 Indicated Conditions 1 Clinical Trials ...